INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 32 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 184,667 | $279,000 | 0.62% |
| IMS Capital Management | 29,536 | $35,000 | 0.03% |
| Paulson Wealth Management Inc. | 11,250 | $4,000 | 0.00% |
| Next Capital Management LLC | 1,139 | $2,000 | 0.00% |
| Renaissance Technologies | 362,282 | $547,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,972 | $39,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 181 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 103 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 40 | $0 | 0.00% |
| NORTHERN TRUST CORP | 15,074 | $23,000 | 0.00% |